Dramedilol
Alternative Names: ISF 3382Latest Information Update: 14 Jan 2005
At a glance
- Originator ISF
- Class Antihypertensives; Hydrazones; Small molecules
- Mechanism of Action Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 06 Sep 2004 Discontinued for Hypertension in Italy (PO)
- 30 May 2001 Profile reviewed but no significant changes made
- 06 Sep 1995 No-Development-Reported for Hypertension in Italy (PO)